T1	Participants 357 472	795 adults with preneoplastic gastric lesions was randomised to receive anti-H pylori treatment and/or antioxidants
T2	Participants 913 1016	Ninety seven per cent of subjects were H pylori positive at baseline, and 53% were positive at 12 years
T3	Participants 23 73	patients treated for Helicobacter pylori infection
